Shares ofSkye Bioscience, Inc. (NASDAQ:SKYE) fell sharply during Monday's session after the company announced its SBI-100 Ophthalmic Emulsion Phase 2a trial did not achieve target product profile and has discontinued the program.

Skye Bioscience shares tumbled 18.9% to $8.87 on Monday.

Here are some other stocks moving in today's mid-day session.

Gainers

• Big Tree Cloud Holdings Limited(NASDAQ:DSY) shares jumped 123% to $4.3001 following the completion of the company's business combination with Plutonian Acquisition Corp. and amid continued volatility following its Nasdaq debut last week.
• KWESST Micro Systems Inc. (NASDAQ:KWE) gained 79.8% to $0.7082 after the company was awarded...